Avenue Therapeutics Inc.

NASDAQ: ATXI · Real-Time Price · USD
0.50
-0.04 (-7.41%)
At close: Aug 11, 2025, 11:48 AM

Avenue Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.7M -10.38M -3.6M -3.73M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
1.24M 906K 649K 442K
Other Working Capital
179K 70K 23K -55K
Other Non-Cash Items
1.25M 310K -5.05M 909K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
179K -290K 408K -461K
Operating Cash Flow
-9.03M -9.45M -7.6M -3.75M
Capital Expenditures
n/a -3M n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -3M n/a n/a
Investing Cash Flow
n/a -3M n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -1.1M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
8.21M 1K 148K -663K
Financial Cash Flow
9.84M 7.53M 10.54M 4.38M
Net Cash Flow
811K -4.92M 2.94M 631K
Free Cash Flow
-9.03M -12.45M -7.6M -3.75M